Shares

7 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 02, 2024

SELL
$151.44 - $200.09 $2,423 - $3,201
-16 Reduced 13.91%
99 $19,000
Q3 2023

Oct 27, 2023

SELL
$167.14 - $192.77 $3,677 - $4,240
-22 Reduced 16.06%
115 $20,000
Q2 2023

Jul 28, 2023

BUY
$160.94 - $186.23 $22,048 - $25,513
137 New
137 $23,000
Q3 2022

Oct 06, 2022

SELL
$148.29 - $182.55 $593 - $730
-4 Reduced 2.23%
175 $25,000
Q1 2022

Apr 26, 2022

BUY
$181.39 - $234.03 $725 - $936
4 Added 2.29%
179 $34,000
Q4 2019

Jan 28, 2020

SELL
$116.25 - $133.25 $20,343 - $23,318
-175 Reduced 50.0%
175 $23,000
Q3 2019

Oct 22, 2019

BUY
$112.57 - $128.43 $39,399 - $44,950
350 New
350 $44,000

Others Institutions Holding ZTS

About Zoetis Inc.


  • Ticker ZTS
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 468,139,008
  • Market Cap $82.7B
  • Description
  • Zoetis Inc. discovers, develops, manufactures, and commercializes animal health medicines, vaccines, and diagnostic products in the United States and internationally. It commercializes products primarily across species, including livestock, such as cattle, swine, poultry, fish, and sheep; and companion animals comprising dogs, cats, and horses. ...
More about ZTS
Track This Portfolio

Track Marquette Asset Management, LLC Portfolio

Follow Marquette Asset Management, LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Marquette Asset Management, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Marquette Asset Management, LLC with notifications on news.